Who's in favor of translational cell therapy for stroke

STEPS forward please?

Michael Chopp, Gary K. Steinberg, Douglas Kondziolka, Mei Lu, Tonya M. Bliss, Yi Li, David C Hess, Cesario V. Borlongan

Research output: Contribution to journalComment/debate

37 Citations (Scopus)

Abstract

A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance from the laboratory to the clinic.

Original languageEnglish (US)
Pages (from-to)691-693
Number of pages3
JournalCell Transplantation
Volume18
Issue number7
DOIs
StatePublished - Nov 9 2009

Fingerprint

Biotechnology
Cell- and Tissue-Based Therapy
Stem cells
Stroke
Industry
Stem Cells

Keywords

  • Cellular therapy
  • Clinical translation
  • Stem cell transplantation
  • Tissue regeneration

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

Chopp, M., Steinberg, G. K., Kondziolka, D., Lu, M., Bliss, T. M., Li, Y., ... Borlongan, C. V. (2009). Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplantation, 18(7), 691-693. https://doi.org/10.3727/096368909X470883

Who's in favor of translational cell therapy for stroke : STEPS forward please? / Chopp, Michael; Steinberg, Gary K.; Kondziolka, Douglas; Lu, Mei; Bliss, Tonya M.; Li, Yi; Hess, David C; Borlongan, Cesario V.

In: Cell Transplantation, Vol. 18, No. 7, 09.11.2009, p. 691-693.

Research output: Contribution to journalComment/debate

Chopp, M, Steinberg, GK, Kondziolka, D, Lu, M, Bliss, TM, Li, Y, Hess, DC & Borlongan, CV 2009, 'Who's in favor of translational cell therapy for stroke: STEPS forward please?', Cell Transplantation, vol. 18, no. 7, pp. 691-693. https://doi.org/10.3727/096368909X470883
Chopp M, Steinberg GK, Kondziolka D, Lu M, Bliss TM, Li Y et al. Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplantation. 2009 Nov 9;18(7):691-693. https://doi.org/10.3727/096368909X470883
Chopp, Michael ; Steinberg, Gary K. ; Kondziolka, Douglas ; Lu, Mei ; Bliss, Tonya M. ; Li, Yi ; Hess, David C ; Borlongan, Cesario V. / Who's in favor of translational cell therapy for stroke : STEPS forward please?. In: Cell Transplantation. 2009 ; Vol. 18, No. 7. pp. 691-693.
@article{cec0a5ff083e454092f167f88acc0044,
title = "Who's in favor of translational cell therapy for stroke: STEPS forward please?",
abstract = "A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance from the laboratory to the clinic.",
keywords = "Cellular therapy, Clinical translation, Stem cell transplantation, Tissue regeneration",
author = "Michael Chopp and Steinberg, {Gary K.} and Douglas Kondziolka and Mei Lu and Bliss, {Tonya M.} and Yi Li and Hess, {David C} and Borlongan, {Cesario V.}",
year = "2009",
month = "11",
day = "9",
doi = "10.3727/096368909X470883",
language = "English (US)",
volume = "18",
pages = "691--693",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "7",

}

TY - JOUR

T1 - Who's in favor of translational cell therapy for stroke

T2 - STEPS forward please?

AU - Chopp, Michael

AU - Steinberg, Gary K.

AU - Kondziolka, Douglas

AU - Lu, Mei

AU - Bliss, Tonya M.

AU - Li, Yi

AU - Hess, David C

AU - Borlongan, Cesario V.

PY - 2009/11/9

Y1 - 2009/11/9

N2 - A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance from the laboratory to the clinic.

AB - A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance from the laboratory to the clinic.

KW - Cellular therapy

KW - Clinical translation

KW - Stem cell transplantation

KW - Tissue regeneration

UR - http://www.scopus.com/inward/record.url?scp=70350641323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350641323&partnerID=8YFLogxK

U2 - 10.3727/096368909X470883

DO - 10.3727/096368909X470883

M3 - Comment/debate

VL - 18

SP - 691

EP - 693

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 7

ER -